RENO, NV -- (MARKET WIRE) -- August 30, 2006 -- Lifeline Biotechnologies, Inc. (www.lbtn.com) (PINKSHEETS: LBTN) today announced that Jim Holmes, CEO and President of Lifeline Biotechnologies, Inc., was featured on MacReport.Net. In his interview, Mr. Holmes updated the investment community on the future direction of the Company, as well as the updates and developments of Lifeline Biotechnologies’ agreement with Solos Endoscopy, Inc. (PINKSHEETS: SLSE) for its three products (MastaScope™, First Warning System™ and the OvaScope™) that are designed to assist in the early detection of breast and ovarian cancers.
